Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Busy address KBO
20 other companies have their registered office at the same address; threshold 10.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2024
Belgian hadron therapy consortium from Oudergem, company number BE0890078631, closed financial year 2024 with a result of € -606 after tax. For that financial year Belgian hadron therapy consortium recorded a gross margin of € -1,144 and equity of € 63,649. Compared with financial year 2023, the result moved from € -3,323 to € -606. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2025.
€ 63,649
▼ 1% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -606
▲ 82 % less loss than in 2023
Profit after tax over the fiscal year.
€ 78,917
▼ 1% vs 2023
Cash and bank balances on the last day of the fiscal year.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € -3,596 | € -6,570 | € -3,545 | € -1,144 | ▲ € 2,401 |
| Profit after taxes | € -3,633 | € -6,650 | € -3,323 | € -606 | ▲ € 2,717 |
| Equity | € 74,228 | € 67,578 | € 64,255 | € 63,649 | ▼ 1% |
| Total debts | € 15,268 | € 15,268 | € 15,268 | € 15,268 | |
| Cash | € 89,496 | € 82,846 | € 79,523 | € 78,917 | ▼ 1% |
| Retained profit | € 74,228 | € 67,578 | € 64,255 | € 63,649 | ▼ 1% |
| Balance sheet total | € 89,496 | € 82,846 | € 79,523 | € 78,917 | ▼ 1% |
Key figures of Belgian hadron therapy consortium, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to Belgian hadron therapy consortium?
What happened at Belgian hadron therapy consortium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 606. Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 3,633 loss in 2021 to € 606 loss in 2024.
Establishments
Establishment units
Physical locations of this company
Herrmann-Debrouxlaan 40
1160 Oudergem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
All companies at this address →Studiecentrum voor Kernenergie - Centre d'Etude de l'Energie Nucléaire
€ 99.3 million revenue · 2025
European Radiation Research Society
Union internationale des Radioécologistes
Belgian Nuclear Society
Cosmetics Europe - the personal Care Assocaition
€ 8.9 million revenue · 2025
+15 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0890.078.631
- VAT number
- BE 0890.078.631
- Registered office
- Herrmann-Debrouxlaan 40, 1160 Oudergem
- Names & denominations
- Belgian hadron therapy consortium
- Enterprise type
- Rechtspersoon
- Legal form
- Private foundation
- Legal situation
- Normale toestand
- Start date
- 30 May 2007
- Peppol
- Not registered
- Contact
- [email protected]